Stephen A. Hurly
Overview
Stephen A. Hurly received an average of $1M in total compensation, including $270K in salary, at Eleven Biotherapeutics from 2016 to 2018.
Source: SEC filings on April 30, 2019, April 30, 2018, and April 7, 2017.
Related executives
We found 16 more executives who work or worked at Eleven Biotherapeutics.
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Glen MacDonald
Eleven Biotherapeutics
Chief Technology Officer
Mark Sullivan
Eleven Biotherapeutics